Source: Emerald Health Therapeutics, Inc.
Senior marketing executive with three decades global consumer packaged goods experience to lead Emerald’s marketing and sales strategy
Emerald Health
Therapeutics Inc. (TSXV:EMH) (OTCQX:EMHTF) (“Emerald”) today announced
the appointment of Paul R. Dillman, Jr., as the Company's Vice President
of Sales and Marketing. Mr. Dillman will be responsible for marketing,
sales, and customer service, and will lead Emerald’s brand strategy and
execution as the Company prepares for anticipated legalization of adult
use cannabis in Canada by July 2018.
“Paul
has been instrumental in preparing for and executing sales growth as a
senior leader at some of the world’s most successful fast-moving
consumer packaged goods companies. His strategic and tactical marketing
expertise will be invaluable as we position Emerald for leadership in
the Canadian and global cannabis industry,” said Chris Wagner, Chief
Executive Officer of Emerald.
Mr. Dillman brings
three decades of experience in global marketing, sales, and general
management to Emerald and has held senior leadership positions at The
Coca-Cola Company, AB InBev, Philip Morris, and Kraft Foods.
Mr.
Dillman earned a Bachelor of Science from West Point (United States
Military Academy) and a Master of Science in Systems Management from the
University of Southern California.
"I'm
thrilled to join the dynamic organization that Emerald is building,”
said Mr. Dillman. “With its current expansion projects and product
innovation plans, Emerald is poised to be a premiere provider of
cannabis for medical and adult-use consumers. I look forward to planning
and executing a marketing and sales strategy that will contribute to
this goal.”
Mr. Dillman has been granted an option to acquire up to 150,000 common shares vesting over three years.
Join us on our journey of making lives better through cannabis science.
About Emerald Health Therapeutics Inc.
Emerald
Health Therapeutics, Inc. (TSXV:EMH) (OTCQX:EMHTF) operates through
Emerald Health Botanicals Inc. ("Botanicals"), a wholly owned subsidiary
and Licensed Producer under Canada’s Access to Cannabis for Medical
Purposes Regulations. Through Botanicals, Emerald is authorized to
produce and sell dried medical cannabis flower and medical cannabis oil.
It currently operates an indoor facility in Victoria, BC, and is
building a 500,000 s.f. greenhouse on 32 acres in Metro Vancouver, with
expansion potential to 1 million s.f. to serve the anticipated legal
Canadian adult-use cannabis market starting in 2018. Emerald also owns
50% of Pure Sunfarms, a partnership with Village Farms that is
converting an existing 1.1 million s.f. greenhouse in Delta, BC from
growing tomatoes to growing cannabis. Emerald’s team is highly
experienced in life sciences, product development and large-scale
agribusiness. Emerald is part of the Emerald Health group,
which is broadly focused on developing pharmaceutical, botanical and
nutraceutical products designed to provide wellness and medical benefits
by interacting with the human body’s endocannabinoid system.
Please visit www.emeraldhealth.ca for more information or contact:
No comments:
Post a Comment